理念与技术并重 提高食管胃结合部腺癌综合治疗水平

To improve the multimodality therapeutic level for adenocarcinoma of the esophagogastric junction based on the concept and surgical competence of surgeons

目前,食管胃结合部腺癌(AEG)作为一类不同于食管癌和胃癌的独立疾病的临床观点已为多数学者所接受。然而,有关AEG根治术的手术径路、切除范围、淋巴结清扫范围等问题仍存在争议。外科医师应重视临床研究结果,同时提高手术技巧。在循证医学的指导下,应综合病人全身情况、AEG类型、cTNM分期等因素,开展多学科团队治疗模式,制定合理的个体化综合治疗方案。

The majority of scholars have agreed that the adenocareinoma of the esophagogastrie junction （AEG） is an independent tumor entity, which is different from squamous cell carcinoma of the esophagus and gastric adenocarcinoma. But there are still many controversies about the surgical approaches, procedures of resection and extent of lymph nodes dissection.Surgeons should pay more attention to the results of recent clinical trials, and practice personal surgical competence. With the guide of evidence-based medicine, clinically, muhidiseiplinary treatment should be carried out for patients with AEG, and the treatment protocol should be tailored individually according to the general condition of the patient, type of AEG, extent of esophageal infiltration, cTNM stage and etc.